Table 1 Sociodemographic and clinical characteristics of the study sample (N = 153)
From: Knowledge of, and attitude towards, the treatment of hepatitis C in people who inject drugs
Sociodemographic characteristics | |||
Age (in years), mean, SD | 45.5 | 9.1 | |
Sex, n, % | Male | 119 | 77.8 |
Female | 34 | 22.2 | |
Education, n, % | Secondary school | 102 | 66.7 |
High school | 24 | 15.7 | |
College | 3 | 2.0 | |
Primary education | 23 | 15.0 | |
Unknown | 1 | 0.7 | |
Occupational qualification, n, % | No | 69 | 45.1 |
Yes | 84 | 54.9 | |
Employment, n, % | Full-time or part-time | 36 | 23.5 |
Odd jobs | 24 | 15.7 | |
Unemployed | 64 | 41.8 | |
Other | 28 | 18.4 | |
Unknown | 1 | 0.7 | |
Partnership, n, % | Yes | 42 | 27.5 |
No | 81 | 52.9 | |
Unknown | 30 | 19.6 | |
Substance use characteristics | |||
Substance use (past 30 days), n, % | None | 26 | 17.0 |
Heroin | 67 | 43.8 | |
Cocaine | 48 | 31.4 | |
Alcohol | 75 | 49.0 | |
Benzodiazepines | 43 | 28.1 | |
Cannabis | 49 | 32.0 | |
Amphetamines | 11 | 7.2 | |
Nicotine | 143 | 93.5 | |
Other | 5 | 3.3 | |
Duration of opioid use disorder (in years), mean, SD | 22.5 | 10.1 | |
Current opioid agonist therapy n, % | 106 | 69.3 | |
Current inpatient detoxification treatment, n, % | 47 | 30.7 | |
Duration of lifetime opioid agonist therapy (in months), mean, SD | 119.4 | 93.9 | |
Duration of current opioid agonist therapy (in months), mean, SD | 53.9 | 66.7 | |
Psychiatric characteristics | |||
Comorbid mental disorder according to ICD-10, n, % | None | 103 | 67.3 |
F2 schizophrenia | 10 | 6.5 | |
F3 affective disorders | 16 | 10.5 | |
F4 anxiety and stress disorders | 15 | 9.8 | |
F6 personality disorders | 20 | 13.1 | |
F9 early onset disorders | 3 | 2.0 | |
Unknown | 2 | 1.3 | |